NCT04853875View on ClinicalTrials.gov

ILTHPI - Comparison of Medicament Containing Tetracycline, Metronidazole, Bismuth Versus Amoxicillin, Metronidazole, Clarithromycin

PHASE4CompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

April 19, 2021

Primary Completion Date

August 30, 2022

Study Completion Date

December 16, 2022

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Tetracycline, Metronidazole, Bismuth subcitrate

52 participants (Group A) are randomly assigned to receive intraluminal eradication of H. pylori with medicament containing Tetracycline, Metronidazole, and Bismuth subcitrate

DRUG

Amoxicillin, Metronidazole, Clarithromycin

52 participants (Group B) are randomly assigned to receive intraluminal eradication of H. pylori with medicament containing Amoxicillin, Metronidazole, and Clarithromycin

Trial Locations (1)

10449

Division of Gastroenterology and Department of Internal Medicine, Mackay Memorial Hospital, Taipei

All Listed Sponsors
lead

Mackay Memorial Hospital

OTHER